Inactive

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health (NIH) intends to award a fi... This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health (NIH) intends to award a fixed price contract with one (1) twelve-month base year to Illumina, Inc., San Diego, California, 92122 on a sole source basis to provide continued maintenance, support and emergency servicing for the MiSeq Sequencer located in the Center for Cellular Engineering (CCE) at the NIH Clinical Center (CC). The MiSeq sequencer is a unique instrument utilized by the CCE to identify gene modification efficiency of clinical engineered cell products to guide and improve cell product administrated to the patient. Preventive maintenance is required for compliance with the MiSeq sequencer manufacturer and FDA 21 CFR 211.67. This instrument is needed to generate data that is required for providing guidance to improve immunotherapy efficiency of the cellular therapy product. Illumina, Inc. is the only vendor that provides the clinically approved platform for reagents, kits, and the respective instruments that may be used for patient care testing for differential gene expression analysis and tracking immunotherapy efficiency and monitoring side effects on clinical and research cellular products. Illumina, Inc. shall provide the most popular full-service plan balancing performance, productivity, and cost to deliver confidence and peace of mind. The full-service plan includes one Annual Preventive Maintenance, full coverage for parts, labor and travel, reagent replacement upon hardware failures, remote technical support 18 hours per day, Monday through Friday. Illumina shall also provide a two (2) business day on-site response target, on-site FAS application support, control software and hardware updates. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Kerry-Ann Chisholm, Contract Specialist, kerry-ann.chisholm@nih.gov by the due date and time marked in this notice.